Crunching the numbers for STEK... Refresh in a moment for the full analysis.
Stemtech Corp (STEK)
weak
$0.0
Updated: 2026-04-13
36
TradeApes Score
reduce
Financial Strength
40
Weak
Operating Trend
38
Weak
Valuation
40
Weak
Capital Allocation
20
Stressed
Risk
35
Weak
Key Findings
+
Net cash position — more cash on hand than total debt
−
Sharp revenue decline — sales down more than 15% year over year
4 free score cards remaining
TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor.
The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.